Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference

Dipak Kotecha, Guenter Breithardt, A. John Camm, Gregory Y. H. Lip, Ulrich Schotten, Anders Ahlsson, David Arnar, Dan Atar, Angelo Auricchio, Jeroen Bax, Stefano Benussi, Carina Blomstrom-Lundqvist, Martin Borggrefe, Giuseppe Boriani, Axel Brandes, Hugh Calkins, Barbara Casadei, Manuel Castella, Winnie Chua, Harry CrijnsDobromir Dobrev, Larissa Fabritz, Martin Feuring, Ben Freedman, Andrea Gerth, Andreas Goette, Eduard Guasch, Doreen Haase, Stephane Hatem, Karl Georg Haeusler, Hein Heidbuchel, Jeroen Hendriks, Craig Hunter, Stefan Kaab, Stefanie Kespohl, Ulf Landmesser, Deirdre A. Lane, Thorsten Lewalter, Lluis Mont, Michael Nabauer, Jens C. Nielsen, Michael Oeff, Jonas Oldgren, Ali Oto, Laurent Pison, Tatjana Potpara, Ursula Ravens, Isabelle Richard-Lordereau, Michiel Rienstra, Irina Savelieva, Renate Schnabel, Moritz F. Sinner, Philipp Sommer, Sakis Themistoclakis, Isabelle C. Van Gelder, Panagiotis E. Vardas, Atul Verma, Reza Wakili, Evelyn Weber, David Werring, Stephan Willems, Andre Ziegler, Gerhard Hindricks, Paulus Kirchhof*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

There are major challenges ahead for clinicians treating patients with atrial fibrillation (AF). The population with AF is expected to expand considerably and yet, apart from anticoagulation, therapies used in AF have not been shown to consistently impact on mortality or reduce adverse cardiovascular events. New approaches to AF management, including the use of novel technologies and structured, integrated care, have the potential to enhance clinical phenotyping or result in better treatment selection and stratified therapy. Here, we report the outcomes of the 6th Consensus Conference of the Atrial Fibrillation Network (AFNET) and the European Heart Rhythm Association (EHRA), held at the European Society of Cardiology Heart House in Sophia Antipolis, France, 17-19 January 2017. Sixty-two global specialists in AF and 13 industry partners met to develop innovative solutions based on new approaches to screening and diagnosis, enhancing integration of AF care, developing clinical pathways for treating complex patients, improving stroke prevention strategies, and better patient selection for heart rate and rhythm control. Ultimately, these approaches can lead to better outcomes for patients with AF.
Original languageEnglish
Pages (from-to)395-407
Number of pages13
JournalEP Europace
Volume20
Issue number3
DOIs
Publication statusPublished - 1 Mar 2018

Keywords

  • Atrial fibrillation
  • Outcomes
  • Quality of care
  • Research
  • Rate control
  • Rhythm control
  • Catheter ablation
  • Anticoagulation
  • Bleeding
  • Research priorities
  • Technology
  • Stroke
  • Integrated care
  • Screening
  • RANDOMIZED CLINICAL-TRIAL
  • AF-TIMI 48
  • RADIOFREQUENCY CATHETER ABLATION
  • SINUS RHYTHM MAINTENANCE
  • STROKE RISK SCORE
  • VS. USUAL CARE
  • HEART-FAILURE
  • INTRACEREBRAL HEMORRHAGE
  • APPENDAGE CLOSURE
  • SHORT-TERM

Cite this